Nasdaq IPOs

Trebia Acquisition, the third blank check company formed by financial services veteran Bill Foley, raised $450 million by offering 45 million units, 7.5 million more than anticipated, at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable

Royalty Pharma (RPRX) jumped 58.9% on Tuesday, the latest and largest in a string of successful IPOs, particularly from the healthcare sector.

BlueCity Holdings, a leading online LGBTQ community and dating platform in China, filed on Tuesday with the SEC to raise up to $50 million in an initial public offering. BlueCity provides a full suite of LGBTQ-focused services centered around the Blued mobile

Royalty Pharma, which buys royalty interests in marketed and late-stage biopharmaceuticals, raised $2.2 billion in the largest US IPO year to date by offering 77.7 million shares at $28, the high end of the range of $25 to $28. The company offered 7.7 million more shares than ant

Royalty Pharma, which buys royalty interests in marketed and late-stage biopharmaceuticals, raised $2.2 billion in the largest US IPO year to date by offering 77.7 million shares at $28, the high end of the range of $25 to $28. The company offered 7.7 million more shares than ant

Therapeutics Acquisition, a blank check company formed by RA Capital targeting the biotech sector, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The company plans to raise an additional $25 million through a forward purchase agreement wit

Companies operate in the real world, but Wall Street prefers buckets when it comes to classifying companies and determining research analyst coverage.

Genetron Holdings, which uses molecular profiling to provide diagnostic services for cancer patients in China, announced terms for its IPO on Monday. The Beijing, China-based company plans to raise $163 million by offering 13 million ADSs at a price range of $11.50 to $13.50. Ins

Progenity, which sells in vitro molecular tests for prenatal and disease screening, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. Insiders intend to purchase $50 mi

Repare Therapeutics, a preclinical biotech developing gene therapies for solid tumors, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint of the proposed

Forma Therapeutics, a Phase 1 biotech company developing therapies for hematologic diseases and cancers, announced terms for its IPO on Monday. The Watertown, MA-based company plans to raise $200 million by offering 11.8 million shares at a price range of $16 to $18. At the midpo

Updated Monday, 6/15. Following back-to-back eight-IPO weeks, the IPO market's summer surge continues with five IPOs scheduled for the week ahead. As expected, several companies launched on Monday with pricing set for later in the week. Pharmaceutical royalty acquirer Royalty Pha

Updated Monday, 6/15. Following back-to-back eight-IPO weeks, the IPO market is taking a breather with four IPOs scheduled for the week ahead. That said, several companies could launch on Monday to price later in the week. Pharmaceutical royalty acquirer Royalty Pharma (RPRX) pla

Following back-to-back eight-IPO weeks, the IPO market is taking a breather with just one IPO scheduled for the week ahead. That said, several companies could launch on Monday to price later in the week. Pharmaceutical royalty acquirer Royalty Pharma (RPRX) plans to raise $1.9 bi

Eight IPOs and one SPAC entered the public markets this past week led by Vroom (VRM), which popped 118% in the best first day for a tech IPO since 2018. Three health care IPOs finished the week up more than 40%. Every IPO this quarter has either upsized its offering or priced abo

PTK Acquisition, a blank check company targeting a technology business, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Los Angeles, CA-based company plans to raise $100 million by offering 10 million units at a price of $10. Each unit

Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The company plans to raise an additional $25 million through a forward purchase agreement wit

NuZee, which packages and sells single-serve coffee products, increased the proposed share offering for its upcoming IPO on Friday. The Plano, TX-based company now plans to raise $6 million by offering 0.7 million shares at $9, the May 20th close of its shares on the OTCQB (NUZE)

Car House Holding, which operates an online B2B marketplace for car products in China, filed on Friday with the SEC to raise up to $37 million in an initial public offering. The company began its business in developing, manufacturing, and selling auto perfume and air fresheners.

Burning Rock Biotech, which provides DNA sequencing-based cancer therapy selection tests in China, raised $223 million by offering 13.5 million ADSs at $16.50, above the range of $13.50 to $15.50. Insiders had indicated on $79 million of the IPO (35% of the deal). The company rai